Classification of the illnesses, etiology (genetic mutations involved in the disease) controlling mechanism involved in the disease (e.g. Blood pressure, Respiration, Glomerular filtration etc.) and pathophysiology, biomarkers, Diagnostic criteria, clinical manifestations, complications, management including pharmacological (including selection of drug with appropriate doses, standard treatment guidelines, newer drugs approved by USFDA, and their Indian market availability, including gene therapy associated with personalized medication, changes in the biomarkers due to therapy, pharmacokinetics and pharmacodynamics of the therapy, ADRs, contraindications with an emphasis on vulnerable population) and non-pharmacological treatment.
Programs
View all programsFrom the news
- AMRITA IQAC Support to Various Autonomous Higher Educational Institutions
- International Yoga Day Celebration 2025
Others
- Transcription Repressor Protein ZBTB25 Associates with HDAC1-Sin3a Complex in Mycobacterium tuberculosis-Infected Macrophages, and Its Inhibition Clears Pathogen by Autophagy
- Crystal Structure And Hirshfeld Surface Analysis Of 1-[2-(2-chloroethoxy)ethyl]-2-methyl-4-nitro-1h-imidazole